Postoperative Analgesia With Local Infiltration After Hip Fracture

This study is currently recruiting participants.

Verified by Odense University Hospital, December 2008

Sponsored by:	Odense University Hospital
Information provided by:	Odense University Hospital
ClinicalTrials.gov Identifier:	NCT00529425

Purpose

Reducing pain is an essential factor for early mobilization after internal fixation of hip fractures. Systemic opioids have side effects that might obstruct mobilization and induce delirium and nausea. The investigators hypothesized that wound infiltration results in reduction in systemic opioid usage and pain relief without side effects.

Condition	Intervention	Phase
Hip Fracture	Drug: Ropivacaine	Phase IV

MedlinePlus related topics: Fractures Hip Injuries and Disorders Hip Replacement

Drug Information available for: Ropivacaine Ropivacaine Hydrochloride Ropivacaine monohydrochloride

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Parallel Assignment, Efficacy Study
Official Title:	Postoperative Analgesia With Local Infiltration After Hip Fracture vs. Traditional Treatment of Pain With Opioids

Further study details as provided by Odense University Hospital:

Estimated Enrollment:	100
Study Start Date:	February 2008

Eligibility

Genders Eligible for Study:

Both

Criteria

Inclusion Criteria:

Pertrochanteric fractures
Femoral neck fractures
Only inclusion of one fracture per patient
Low-energy trauma
Ability to understand danish and give informed consent
Ability to walk

Exclusion Criteria:

Refusal to participate
Substance abuse
Drug intolerance
Pathological fractures
Inverse fractures
Intraarticular inflammation

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00529425

Contacts

Contact: Rune Dueholm Bech, MD

+45 6611 3333 ext 4668

rune.bech@dadlnet.dk

Locations

Denmark
Odense University Hospital	Recruiting
Odense, Denmark, 5000
Contact: Rune D. Bech, MD +45 6611 3333 ext 4668 rune.bech@dadlnet.dk

Sponsors and Collaborators

Odense University Hospital

Investigators

Study Chair:

Soeren Overgaard, Professor, MD, DmSc

Odense University Hospital, DK-5000 Odense C, Denmark

More Information

Study ID Numbers:	S-VF-20060072
Study First Received:	September 12, 2007
Last Updated:	December 29, 2008
ClinicalTrials.gov Identifier:	NCT00529425
Health Authority:	Denmark: Danish Dataprotection Agency

Study placed in the following topic categories:

Hip Fractures
Femoral Fractures
Ropivacaine
Fractures, Bone

Wounds and Injuries
Disorders of Environmental Origin
Leg Injuries
Pain

Additional relevant MeSH terms:

Sensory System Agents
Therapeutic Uses
Physiological Effects of Drugs
Central Nervous System Depressants
Anesthetics

Peripheral Nervous System Agents
Hip Injuries
Central Nervous System Agents
Pharmacologic Actions
Anesthetics, Local

ClinicalTrials.gov processed this record on January 15, 2009